Sartorius Stedim Biotech SA
LSE:0RG8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sartorius Stedim Biotech SA
LSE:0RG8
|
FR |
|
M
|
Macy's Inc
F:FDO
|
US |
|
AnaptysBio Inc
NASDAQ:ANABV
|
US |
Dividends
Dividend Yield
Sartorius Stedim Biotech SA
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Sartorius Stedim Biotech SA
0RG8 have increased by 35%.
Payout Ratio
Sartorius Stedim Biotech SA
| Current Payout | |
| Min Payout | |
| Max Payout | |
| Average Payout | |
| Median Payout |
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for
0RG8 is
.
Peers Comparison
Shareholder Yield
Price Appreciation
0RG8 Price
Sartorius Stedim Biotech SA
| Average Annual Return | -13.69% |
| Standard Deviation of Annual Returns | 22.34% |
| Max Drawdown | -73% |
| Market Capitalization | 15.2B EUR |
| Shares Outstanding | 246 544 842 |
| Percentage of Shares Shorted |
N/A
|
0RG8 Return Decomposition
Main factors of price return
Stock Splits
0RG8's latest stock split occurred on May 6, 2016
The company executed a 6-for-1 stock split, meaning that for every share held, investors received 6 new shares.
Before the split, 0RG8 traded at 321.5 per share. Afterward, the share price was about 312.511.
The adjusted shares began trading on May 6, 2016. This was the only stock split in 0RG8's history.